CAPTRUST Financial Advisors’s Antares Pharma, Inc. ATRS Stock Holding History

CAPTRUST Financial Advisors’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,160	Closed	-$13K	–	5309
2022 Q1	$13K	Buy	3,160 +293	+10%	+$1.06K	﹤0.01%	3681
2021 Q4	$10K	Buy	2,867 +460	+19%	+$1.61K	﹤0.01%	3743
2021 Q3	$9K	Buy	2,407 +25	+1%	+$101	﹤0.01%	3701
2021 Q2	$10K	Hold	2,382	–	–	﹤0.01%	3569
2021 Q1	$10K	Buy	2,382 +382	+19%	+$1.66K	﹤0.01%	3460
2020 Q4	$8K	Hold	2,000	–	–	﹤0.01%	2682
2020 Q3	$6K	Hold	2,000	–	–	﹤0.01%	2496
2020 Q2	$5K	Buy	+2,000	New	+$5.58K	﹤0.01%	2411

Other funds holding ATRS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

CAPTRUST Financial Advisors's ATRS Position: Q2 2022 in Review

CAPTRUST Financial Advisors sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 3,160 shares — an estimated $13K sold.

CAPTRUST Financial Advisors first reported a position in ATRS in Q2 2020 and held it in 8 quarters. The position peaked at $13K in Q1 2022. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

CAPTRUST Financial Advisors reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
CAPTRUST Financial Advisors sold 3,160 Antares Pharma, Inc. shares in Q2 2022, an estimated $13K.
CAPTRUST Financial Advisors first reported a position in Antares Pharma, Inc. in Q2 2020 and held it in 8 quarters.
CAPTRUST Financial Advisors's Antares Pharma, Inc. position peaked at $13K in Q1 2022.
1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2022, filed 16 Aug 2022.